Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05120544 · ClinicalTrials.gov registry record · NA

Expanding Technology-Enabled Nurse Delivered Chronic Disease Care

A NA study of Hypertension and Diabetes Mellitus, Type 2, sponsored by Duke University.

Completed
Registry status
NA
Development phase
220
Enrollment target
1
Study location

NCT05120544 is a NA study of Hypertension and Diabetes Mellitus, Type 2 that has completed, run by Duke University. The registered enrollment target is 220 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05120544, a NA study of Hypertension and Diabetes Mellitus, Type 2, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
220 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to investigate whether the self-management of diabetes and hypertension can be improved with the use of mobile monitoring devices and nursing support.

Interventions

  • BEHAVIORAL EXTEND Plus
  • BEHAVIORAL EXTEND

Study Locations (1)

North Carolina

  • Duke University Medical Center - Durham

Trial Details

FieldValue
Enrollment Target 220 participants
Start Date 2022-04-21
Est. Completion 2025-08-13
Phase NA

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT05120544

The ClinicalTrials.gov registry entry for NCT05120544 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 220 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (94% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Hypertension appearing as the primary indexed condition, and to 2 interventions - of which EXTEND Plus is the first listed.

NCT05120544 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT05120544 about?

NCT05120544 is a clinical study titled "Expanding Technology-Enabled Nurse Delivered Chronic Disease Care". The purpose of this study is to investigate whether the self-management of diabetes and hypertension can be improved with the use of mobile monitoring devices and nursing support.

What is the current status of trial NCT05120544?

This trial is currently completed. It is a NA study. The enrollment target is 220 participants. The study started on 2022-04-21. Estimated completion is 2025-08-13.

What conditions does trial NCT05120544 study?

This clinical trial studies the following conditions: Hypertension, Diabetes Mellitus, Type 2.

What interventions are being tested in trial NCT05120544?

The interventions under investigation include: EXTEND Plus (BEHAVIORAL), EXTEND (BEHAVIORAL).

Who is sponsoring clinical trial NCT05120544?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05120544 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.